USPTO serial 98590242
OES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 21, 2025
- Examiner
- ODUSAMI, OLUWAKEMI KEHINDE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with OES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Personal Genomics Taiwan, Inc.
Zhubei, Hsinchu, TW
Personal Genomics Taiwan, Inc.
Zhubei, Hsinchu, TW
Personal Genomics Taiwan, Inc.
Zhubei, Hsinchu, TW
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janet F. Satterthwaite
Janet F. Satterthwaite Potomac Law Group, PLLC1717 Pennsylvania Ave., NW, Suite 1025Washington, DC 20006United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for use in nucleic acids sequencing in scientific research; Enzymes for use in nucleic acids sequencing in scientific research; Reagents for use in biological processing, namely, reagents for use in scientific apparatus for biological analysis; Biological preparations for enzymatic reactions laboratory research, gene identification, and molecule sequencing identification, other than for medical or veterinary purposes; Stem cells other than for medical or veterinary purposes; Biological tissue cultures other than for medical or veterinary purposes; Diagnostic reagents for clinical laboratory use; Diagnostic enzymes for use in nucleic acids sequencing for clinical laboratory purposes | ACTIVE | — |
| 005 | Medical reagents for use in nucleic acids sequencing for clinical and medical diagnostic purposes; Enzymes for use in nucleic acids sequencing for clinical and diagnostic medical purposes; Biological preparations for analysis of cancer progression, treatment effectiveness, and metastasis risk for the treatment of cancer; Biomarker diagnostic reagents for medical purposes; Test paper being reagent paper for medical purposes; Chemical reagent for medical purposes, stem cells for medical purposes; Enzymes for medical purposes; Enzyme preparations for medical purposes; Reagents for use in biological processing, namely, medical reagents for processing human liquid biopsy in the medical field | ACTIVE | — |
| 009 | Nucleic acid sequencers used for analyzing nucleic acids in scientific research; Imaging devices other than x-ray apparatus used for analyzing nucleic acid sequence in scientific research; Biochip readers for research or scientific purposes; Biochip testing machines for research or scientific purposes; Biochips for research and scientific purposes; DNA chips; Laboratory apparatus for screening samples, detecting the presence of analytes in samples, and identifying sample type, together with measuring patterns and equipment for making and screening molecular arrays; Scientific instruments for genetic analysis; Downloadable computer software for scientific analysis of genetic sequences; Semiconductor chips or silicon dioxide chips having multi-well arrays that are used for genetic sequencing and biochemical analysis in scientific, laboratory, and medical research; Silicon dioxide chips having multi-well arrays that are used for genetic sequencing and biochemical analysis in scientific, laboratory, and medical research | ACTIVE | — |
| 010 | Clinical and medical devices, namely, nucleic acid sequencers and non-X-ray biological imaging devices used for analyzing nucleic acids, genetic sequencing and genetic mutation detection for use in the medical treatment of cancer; Diagnostic apparatus for DNA and RNA exams for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Personal Genomics Taiwan, Inc.
- Other trademarks owned by Personal Genomics Taiwan, Inc.
- Other trademarks owned by Personal Genomics Taiwan, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named OES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 21, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 2, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 2, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 27, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 8, 2025 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 17, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 6, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 7, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 6, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 5, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 5, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 23, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 23, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 22, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 21, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 7, 2024 | NWAP | NEW APPLICATION ENTERED | — |